Fig. 1

SEC61G expression in LUAD and other different types of human cancers from TCGA data. A Expression levels of SEC61G in LUAD and normal tissue; B The expression of SEC61G in LUAD and its paired adjacent tissues; C Receiver operating characteristic analysis (ROC) of SEC61G in LUAD; D The level of SEC61G expression in different tumor types from the TCGA database in TIMER. E The association of SEC61G expression and T classification in LUAD; F The association of SEC61G expression and N classification in LUAD; G The association of SEC61G expression and pathological stages in LUAD. (*P < 0.05, **P < 0.01, ***P < 0.001)